Jefferies Group LLC Reiterates $93.00 Price Target for Walgreens Boots Alliance, Inc. (WBA)

Jefferies Group LLC set a $93.00 price objective on Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in a research note published on Sunday, October 29th. The firm currently has a buy rating on the pharmacy operator’s stock.

Several other research analysts have also weighed in on the company. Needham & Company LLC set a $94.00 price target on Walgreens Boots Alliance and gave the stock a buy rating in a research report on Monday, July 17th. Pivotal Research set a $85.00 price target on Walgreens Boots Alliance and gave the stock a hold rating in a research report on Sunday, July 2nd. Guggenheim reaffirmed a buy rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Loop Capital set a $90.00 price target on Walgreens Boots Alliance and gave the stock a buy rating in a research report on Thursday, October 26th. Finally, Morgan Stanley reaffirmed an overweight rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have assigned a buy rating to the stock. Walgreens Boots Alliance presently has a consensus rating of Buy and an average price target of $87.63.

Walgreens Boots Alliance (WBA) opened at $70.59 on Friday. Walgreens Boots Alliance has a 1-year low of $63.82 and a 1-year high of $88.00. The firm has a market capitalization of $71,667.88, a PE ratio of 13.92, a PEG ratio of 1.26 and a beta of 1.20. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The business had revenue of $30.15 billion for the quarter, compared to analyst estimates of $29.93 billion. During the same quarter last year, the firm earned $1.07 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 5.3% compared to the same quarter last year. analysts forecast that Walgreens Boots Alliance will post 5.55 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This report was originally published by Week Herald and is the sole property of of Week Herald. If you are accessing this report on another publication, it was stolen and republished in violation of United States & international copyright & trademark laws. The original version of this report can be viewed at https://weekherald.com/2017/11/15/walgreens-boots-alliance-inc-wba-given-a-93-00-price-target-at-jefferies-group-llc.html.

Walgreens Boots Alliance declared that its board has approved a share repurchase program on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to buy shares of its stock through open market purchases. Shares buyback programs are generally a sign that the company’s board believes its shares are undervalued.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.27%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 42.33%.

In other news, Director John Anthony Lederer bought 20,000 shares of the stock in a transaction on Thursday, October 26th. The stock was acquired at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the acquisition, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the transaction, the director now directly owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. 13.50% of the stock is currently owned by insiders.

Several hedge funds have recently modified their holdings of the company. Hudock Capital Group LLC increased its stake in shares of Walgreens Boots Alliance by 0.5% in the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 6 shares during the period. Modera Wealth Management LLC increased its stake in shares of Walgreens Boots Alliance by 0.4% in the first quarter. Modera Wealth Management LLC now owns 2,451 shares of the pharmacy operator’s stock valued at $204,000 after buying an additional 9 shares during the period. Flagship Harbor Advisors LLC increased its stake in shares of Walgreens Boots Alliance by 0.5% in the first quarter. Flagship Harbor Advisors LLC now owns 3,027 shares of the pharmacy operator’s stock valued at $243,000 after buying an additional 16 shares during the period. Sowell Financial Services LLC increased its stake in shares of Walgreens Boots Alliance by 0.6% in the first quarter. Sowell Financial Services LLC now owns 2,703 shares of the pharmacy operator’s stock valued at $218,000 after buying an additional 17 shares during the period. Finally, WealthTrust Arizona LLC increased its stake in shares of Walgreens Boots Alliance by 0.4% in the second quarter. WealthTrust Arizona LLC now owns 5,264 shares of the pharmacy operator’s stock valued at $412,000 after buying an additional 21 shares during the period. 63.58% of the stock is owned by institutional investors.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply